Back to Journals » International Journal of General Medicine » Volume 16

Poor Seizure Control Among Children Attending a Tertiary Hospital in South Western Uganda – A Retrospective Study [Letter]

Authors Mangundap SA 

Received 15 March 2023

Accepted for publication 21 March 2023

Published 22 March 2023 Volume 2023:16 Pages 1059—1060

DOI https://doi.org/10.2147/IJGM.S412638

Checked for plagiarism Yes

Editor who approved publication: Prof. Dr. Luca Testarelli



Selvi A Mangundap

Department of Nursing, Poltekkes Kemenkes Palu, Palu, Indonesia

Correspondence: Selvi A Mangundap, Faculty of Nursing, Poltekkes Kemenkes Palu, Thalua Konchi Street Number 09, North Palu, Palu, Center Sulawesi, Indonesia, Email [email protected]


View the original paper by Dr Namusisi and colleagues

A Response to Letter has been published for this article.


Dear editor

We have read the paper by Jane Namusisi et al on Poor Seizure Control Among Children Attending a Tertiary Hospital in South Western Uganda.1 This study helps us to assess the factors that cause seizure control in children with epilepsy, including the medication given. We would like to share our views about this study because mismanagement of epilepsy can have a negative impact on the quality of life of children who suffer from it. In addition, the cost of treating epilepsy is also an economic burden that needs to be considered.2

The study conducted by Jane Namusisi et al aimed to determine seizure control status and factors related to control among Children with Epilepsy (CWE) who received Anti-Seizure Medications (ASM).1 The results found that three-quarters of the correspondents had generalized onset seizures and the remainder had unrecognized focal and motor seizures. However, because the data obtained using medical records, it is difficult for researchers to determine matters related to the seizure onset, nature, and duration of the seizure when the patient comes to the hospital.3 In addition, in this study we did not find any risk factors underlying the evaluation of epilepsy patients such as neurological examination, cerebral imaging, electroencephalographic findings, and laboratory tests including complete blood count and biochemical profile, all of which were assessed by a team of neurologists, pediatricians and emergency doctors.3

The study conducted by Jane Namusisi et al was a retrospective review of charts, socio-demographic and clinical data obtained from medical records. Physical or telephone interviews were conducted with the patient’s direct caregiver.1 This method was quite effective although the researcher acknowledged that some telephone contacts were not available online at the time of data collection. We suggest that researchers also complete data on recurrence factors in patients such as the number of antiepileptic drugs (AED), electroencephalogram (EEG) data and seizure-free time, because all of these data will help in assessing factors that cause seizure control in children with epilepsy.4

In conclusion we agree that seizure control in Children with Epilepsy (CWE) receiving Anti-Seizure Medications (ASM) at MRRH is still poor.1 However, the hospital has been trying to overcome seizure control and optimize the drug needed. We recommend that future studies can provide genetic analysis data representing detailed individual phenotypes to assist in the interdisciplinary treatment and prognosis of patients who have complicated neurodevelopmental disorders. This will also help the doctor who gives the therapy to determine the right pharmacotherapy.5 In addition, a public health plan is needed to co-manage epilepsy with traditional medicine because people in remote rural areas play an important role for patients in their local communities.2

Disclosure

The author reports no conflict of interest in this communication.

References

1. Namusisi J, Kyoyagala S, Nantongo J, et al. Poor seizure control among children attending a tertiary Hospital in South Western Uganda – a Retrospective Study. Int J Gen Med. 2023;16:895–904. doi:10.2147/IJGM.S398318

2. Teuwen DE, Sebera F, Murekeyiteto A, et al. Epilepsy-related direct medical and direct non-medical cost in adult patients living with Epilepsy at a Tertiary neurology center in Rwanda. Clin Outcomes Res. 2023;15:15–27. doi:10.2147/CEOR.S382030

3. Sheikh hassan M, Sidow NO, Ali Adam B, Gökgül A, Hassan Ahmed F, Ali IH. Epidemiology and risk factors of convulsive status epilepticus patients admitted in the emergency department of Tertiary Hospital in Mogadishu, Somalia. Int J Gen Med. 2022;15:8567–8575. doi:10.2147/ijgm.s391090

4. Zhang X, Zeng J, Gu X, et al. Relapse after drug withdrawal in patients with epilepsy after two years of seizure-free: a cohort study. Neuropsychiatr Dis Treat. 2023;19:85–95. doi:10.2147/NDT.S390280

5. Verhoeven W, Zuijdam J, Scheick A, et al. Myoclonic-atonic epilepsy caused by a novel de novo heterozygous missense variant in the SLC6A1 gene: brief discussion of the literature and detailed case description of a severely intellectually disabled adult male patient. Int Med Case Rep J. 2022;15:753–759. doi:10.2147/imcrj.s390636

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.